(endo) type II diabetes mellitus Flashcards

1
Q

what is type II diabetes mellitus?

A

a condition that occurs arises as a result of insulin resistance and beta cell failure causing chronic hyperglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is type II diabetes mellitus associated with?

A

associated w obesity (and genetic risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how is the resultant hyperglycaemia of T2DM managed most commonly?

A

most commonly initially managed by changes to diet + weight loss

with time, may need insulin therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how does the age at which T2DM develops affect life expectancy?

A

if diagnosed later in life = not much change in life expectancy

if diagnosed earlier in life = reduces life expectancy a fair amount

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the stages of T2DM development?

A

1) normal
2) intermediate state
3) T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what results are expected in normal healthy patients for the following tests?

1) fasting glucose levels
2) 2-hour glucose OGTT
3) HbA1c

A

1) fasting glucose = <6 mmol/L
2) OGTT = <7.7 mmol/L
3) HbA1c = <42 mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what results are expected in T2DM patients for the following tests?

1) fasting glucose levels
2) 2-hour glucose OGTT
3) HbA1c

A

1) fasting glucose = >7 mmol/L
2) OGTT = >11 mmol/L
3) HbA1c = >48 mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is it the term to describe a fasting glucose level between 6-7 mmol/L?

A

impaired fasting glycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is it the term to describe a OGTT between 7.7-11 mmol/L?

A

impaired glucose tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is it the term to describe a HbA1c between 42-48 mmol/mol?

A

pre-diabetes

non-diabetic hyperglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

explain how insulin resistance and insulin production change as T2DM develops

A

insulin production is high and resistance is low in healthy patients

progressively, insulin resistance increases and to compensate, initially, insulin production increases

by the time T2DM develops, insulin resistance peaks and insulin production falls very low
(as beta cell failure occurs due to persistent insulin resistance even after increased production)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the biggest contributory factor to the development of T2DM?

A

insulin resistance

but a degree of beta cell failure is required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what random glucose level allows for a diagnosis of diabetes?

A

a random glucose levels of = 11.1 mmol/L

+ SYMPTOMS

= diagnosis of diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

explain how beta cell failure occurs in T2DM

A

there is compensatory insulin production by beta cells as a response to the increasing insulin resistance in developing T2DM

insulin production begins to wane + cannot keep up w/reverse the insulin resistance
= beta cell failure (due to being overworked)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

patients w T1DM have absolute insulin deficiency

patients w T2DM have relative insulin deficiency

differentiate between the two

A

absolute insulin deficiency = no insulin production at all due to autoimmune damage to the beta cells of the pancreas

relative insulin deficiency = some insulin production occurs BUT is not sufficient enough to overcome the insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

why does T2DM no usually lead to ketogenesis?

A

normally w T2DM = there is RELATIVE, not absolute insulin deficiency

so there is sufficient insulin to inhibit ketogenesis in the liver

= reducing the risk of diabetic ketoacidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

in which scenarios do patients w T2DM present with DKA?

A

possible due to infection, sepsis etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is the biggest risk with long-duration T2DM?

A

long duration can lead to absolute insulin deficiency as the overworked beta cells lose their function completely eventually

= no insulin production at all
= DKA risk (if not on insulin therapy, which is unlikely at this stage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what underpins the pathophysiology of T2DM?

A
adipocytokines
internal adiposity
insulin resistance
beta cell failure
genetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is the response of the following individuals to an IV glucose challenge?

a) normal glucose tolerance
b) impaired glucose tolerance
c) T2DM

(describe the glucose levels initially and the level of insulin production)

A

a) normal glucose levels initially; followed by a sharp peak of insulin release (first + second phase)
b) slightly higher than normal glucose levels; followed by a medium peak in insulin levels
c) very high glucose levels; followed by no/negligible peak in insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

first phase insulin release is lost in patients w T2DM

what does this meal?

A

in response to a meal, stored insulin is released as part of the first phase insulin response in the first 10 mins and then over the next 2-3 hours, in the second phase insulin response, more insulin is produced

in T2DM, no stored insulin is released (i.e. first phase insulin release) is lost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what are the main implications of a lack of insulin in T2DM?

A

reduced/no insulin (also increases glucagon secretion)
= less glucose uptake into myocytes and hepatocytes
= increased glycogenolysis + gluconeogenesis
= increased HGO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

the metabolic clearance rate of glucose in T2DM is significantly diminished

why is this the case?

A

in T2DM, no insulin
= no glucose uptake into hepatocytes + no subsequent conversion into glycogen for storage
= resultant excess glucose is converted into lactate
= lactate then taken to liver and converted into glucose
= increases plasma glucose even more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

why does gluconeogenesis increase in T2DM?

A

in T2DM, no insulin
= increased lipolysis and proteolysis
= increased released of substrates (i.e. glycerol, NEFAs, gluconeogenic AAs)
= influx of substrates in the liver that can be used for gluconeogenesis

(further stimulated by increased glucagon secretion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

describe the relationship between insulin sensitivity and insulin secretion

A

the more insulin sensitive an individual is, the less insulin needs to be secreted to produce the desired effect

(more insulin sensitive individuals are less insulin resistant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

in T2DM, there is an excess of inflammatory adipokines

explain the pathology behind this briefly

A

T2DM
= excess inflammatory adipokines released by adipocytes
= creates a pro-inflammatory toxic state
= drives insulin resistance in tissues

27
Q

differentiate between monogenic and polygenic in terms of T2DM

A

monogenic = single gene mutation
(born w mutation, always going to develop diabetes)

polygenic = loads of small changes ‘polymorphisms’ in the genome
(not born w it but polymorphisms increase risk of developing diabetes)

– lifestyle changes will only make a difference in the polygenic version –

28
Q

what is the role of obesity in T2DM?

A
  • obesity is a risk factor for T2DM
  • obesity is associated w fatty acids & adipocytokines that are involved in T2DM
  • central/visceral obesity
29
Q

besides obesity, which other associations with T2DM exist?

A
  • perturbations in gut microbiota

- intrauterine growth retardation

30
Q

how does T2DM present?

A
  • overweight
  • hyperglycaemia
  • dyslipidaemia
  • complications (retinopathy, neuropathy, nephropathy, PCD)
  • insulin resistance that can deteriorate to insulin deficiency
31
Q

what are the risk factors of T2DM?

A
  • age
  • ethnicity
  • family history
  • increased BMI/obesity
  • PCOS
  • inactivity
32
Q

what is the first line test for diagnosing T2DM?

A

HbA1c

33
Q

how is T2DM formally diagnosed?

A

1) symptoms
+ x1 HbA1c >48 mmol/L

2) asymptomatic
+ x2 HbA1c >48 mmol/L

34
Q

what are the acute and chronic complications of T2DM?

A

acute =
hyperosmolar hyperglycaemic state

chronic =

1) microvascular: retinopathy, neuropathy, nephropathy
2) macrovascular: ischaemic heart disease, peripheral vascular disease

35
Q

compare the acute complication of T1DM to that of T2DM

A

T1DM = diabetic ketoacidosis

T2DM = hyperosmolar hyperglycaemic state

36
Q

what is a hyperosmolar hyperglycaemic state?

A

the acute complication of T2DM
= when the insulin level is at a point that is sufficient enough to suppress lipolysis and ketogenesis but is insufficient to prevent hyperglycaemia

(= absence of significant acidosis)

37
Q

what does a hyperosmolar hyperglycaemic state commonly present with?

A

renal failure

38
Q

what causes a hyperosmolar hyperglycaemic state?

A

ofter an identificable precipitating event

e.g. infection, MI

39
Q

what does unchecked gluconeogenesis lead to?

A

hyperglycaemia

40
Q

what is the main implications of hyperglycaemia?

A

causes osmotic diuresis

which leads to dehydration

41
Q

how does hyperglycaemia cause osmotic diuresis?

A

hyperglycaemia
= increases osmolarity of the blood in the intravascular space
= water follows in order to maintain the osmotic gradient
= osmotic diuresis
= dehydration

42
Q

how can DKA and the hyperosmolar hyperglycaemic state be differentiated?

A

mainly
1) glucose levels
DKA = >11 mmol/L
HHS = >30 mmol/L

2) osmolarity
DKA = variable
HHS = >320 mOsm/L

43
Q

how are both DKA and HHS managed?

A
  • intravenous fluids

- insulin

44
Q

compare how T1DM is managed compared to T2DM

A

T1DM = exogenous insulin, self-monitoring of glucose, technology, structured education

T2DM = diet, lifestyle changes, oral meds, structured education

45
Q

what are the aspects of a T2DM progress consultation?

A

1) glycaemia (HbA1c, glucose)
2) dyslipidaemia
3) blood pressure
4) weight assessment
5) complication screening (retinal screening; foot check)

46
Q

what dietary recommendations are usually made for patients w T2DM?

A
  • total calorie reduction
  • decrease sodium
  • increase calories as complex carbs + increase soluble fibre
  • reduce calories as fats and refined carbs
47
Q

how is the excess hepatic glucose output managed in patients w T2DM?

A

reduce HGO

= METFORMIN

48
Q

how is the insulin resistance managed in patients w T2DM?

A

improve insulin sensitivity

= METFORMIN, thiozolidinediones

49
Q

how is the inadequate insulin secretion (disproportionate to resistance) managed in T2DM?

A

boost insulin secretion
= DPP-4 inhibitors
= sulphonlyureas
= GLP-1 agonists

50
Q

how is the hyperglycaemia managed in T2DM?

A

inhibit gut absorption + renal reabsoprtion
= alpha glucosidase inhibitor
= SLGT-2 inhibitor

51
Q

when is metform used to manage T2DM and how does it work?

A

first line if lifestyle changes do no make a difference

  • insulin sensitiser
  • reduce HGO + increase peripheral glucose disposal
52
Q

when can metformin not be used to manage T2DM?

A
  • contraindicated in sever cardiac/liver failure or moderate renal failure
  • GI side effects
53
Q

why are sulphonylureas used to manage T2DM and how do they work?

A

increase insulin secretion

= bind to the ATP-sensitive K+ channel, reducing K+ efflux so more remains within th ebeta cells and activates, in turn, the Ca2+
= subsequent Ca2+ influx results in vesicle exocytosis of insulin into the bloodstream

54
Q

what is pioglitazone?

A
  • insulin sensitiser
    = side effects of hepatitis and heart failure

(makes the action o f insulin more efficacious at tissue level)

55
Q

what is GLP-1?

A

gut hormone

= glucagon like peptide-1

56
Q

what is the function of GLP-1?

A

a gut hormone, secreted from L cells mainly

= that stimulates insulin and suppresses glucagon + promotes feelings of satiety (‘fullness’)

57
Q

why does GLP-1 have a short half-life and why is this important?

A

due to the action of the dipeptidyl-peptidase enzyme
= cause rapid degeneration of GLP-1

soooo
= important as DPP-4 inhibitors can prevent degradation of GLP1-
= so more remains to increase insulin and promote satiety

58
Q

what is the GI ‘incretin’ effect?

A

when glucose is taken orally as opposed to intravenously, there is a more significant increase in plasma insulin levels
= mediated by the gut GLP-1 hormone

59
Q

what effect do both GLP-1 agonists and DPP-4 inhibitors have?

A

both increase the half-life of exogenous GLP-1

= increase GLP-1, decrease glucagon and increase insulin

60
Q

why are GLP-1 agonists sometimes preferred to DPP-4 inhibitors?

A

GLP-1 agonists = weight loss

DPP-4 inhibitors = weight neutral

61
Q

what are SGLT-2 inhibitors and how are they used to manage T2DM?

A

used to tackle the hyperglycaemia associated w T2DM

= bind to and inhibit the sodium-glucose transporter
= results in glycosuria BUT improves CKD and HbA1c levels

62
Q

what has the potential to induce remission of T2DM?

A
  • gastric bypass surgery
  • low-calorie diet
  • weight loss
63
Q

besides management of the hyperglyceamia, what else has to be monitored in T2DM patients?

A

1) lipid management
- total cholesterole/triglycerides raised?
- HDL cholesterol reduced?

2) BP management
- hypertension common

64
Q

what does cardiovascular risk management involve in patients w T2DM?

A

lowering HbA1c but addressing blood pressure and lipids too